{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T16:36:57Z","timestamp":1772728617454,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Bio & Medical Technology Development Program of the National Research Foundation","award":["2012M3A9C6049783"],"award-info":[{"award-number":["2012M3A9C6049783"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12967-016-0963-0","type":"journal-article","created":{"date-parts":[[2016,7,8]],"date-time":"2016-07-08T12:29:38Z","timestamp":1467980978000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["GRIM19 ameliorates acute graft-versus-host disease (GVHD) by modulating Th17 and Treg cell balance through down-regulation of STAT3 and NF-AT activation"],"prefix":"10.1186","volume":"14","author":[{"given":"Min-Jung","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung Hoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung-Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun-Kyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun Jung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young-Mee","family":"Moon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mi-","family":"La Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,7,8]]},"reference":[{"issue":"5","key":"963_CR1","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nri2000","volume":"7","author":"WD Shlomchik","year":"2007","unstructured":"Shlomchik WD. Graft-versus-host disease. Nat Rev Immunol. 2007;7(5):340\u201352.","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"963_CR2","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.4049\/jimmunol.136.10.3543","volume":"136","author":"R Parkman","year":"1986","unstructured":"Parkman R. Clonal analysis of murine graft-vs-host disease. I. Phenotypic and functional analysis of T lymphocyte clones. J Immunol. 1986;136(10):3543\u20138.","journal-title":"J Immunol"},{"issue":"20","key":"963_CR3","doi-asserted-by":"crossref","first-page":"4327","DOI":"10.1182\/blood-2009-06-204669","volume":"114","author":"G Socie","year":"2009","unstructured":"Socie G, Blazar BR. Acute graft-versus-host disease: from the bench to the bedside. Blood. 2009;114(20):4327\u201336.","journal-title":"Blood"},{"issue":"9","key":"963_CR4","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1097\/00007890-200205150-00001","volume":"73","author":"A Moine Le","year":"2002","unstructured":"Le Moine A, Goldman M, Abramowicz D. Multiple pathways to allograft rejection. Transplantation. 2002;73(9):1373\u201381.","journal-title":"Transplantation"},{"key":"963_CR5","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1600-065X.1997.tb00976.x","volume":"157","author":"BR Blazar","year":"1997","unstructured":"Blazar BR, Korngold R, Vallera DA. Recent advances in graft-versus-host disease (GVHD) prevention. Immunol Rev. 1997;157:79\u2013109.","journal-title":"Immunol Rev"},{"issue":"4","key":"963_CR6","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/bmt.2013.215","volume":"49","author":"F Malard","year":"2014","unstructured":"Malard F, et al. Increased Th17\/Treg ratio in chronic liver GVHD. Bone Marrow Transplant. 2014;49(4):539\u201344.","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"963_CR7","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.bbmt.2013.06.013","volume":"19","author":"Y Liu","year":"2013","unstructured":"Liu Y, et al. The expression of Th17-associated cytokines in human acute graft-versus-host disease. Biol Blood Marrow Transplant. 2013;19(10):1421\u20139.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"963_CR8","doi-asserted-by":"crossref","first-page":"e86062","DOI":"10.1371\/journal.pone.0086062","volume":"9","author":"EJ Yang","year":"2014","unstructured":"Yang EJ, et al. EGCG attenuates autoimmune arthritis by inhibition of STAT3 and HIF-1alpha with Th17\/Treg control. PLoS ONE. 2014;9(2):e86062.","journal-title":"PLoS ONE"},{"key":"963_CR9","doi-asserted-by":"crossref","first-page":"351856","DOI":"10.1155\/2014\/351856","volume":"2014","author":"J Jhun","year":"2014","unstructured":"Jhun J, et al. Red ginseng extract ameliorates autoimmune arthritis via regulation of STAT3 pathway, Th17\/Treg balance, and osteoclastogenesis in mice and human. Mediators Inflamm. 2014;2014:351856.","journal-title":"Mediators Inflamm"},{"issue":"43","key":"963_CR10","doi-asserted-by":"crossref","first-page":"33416","DOI":"10.1074\/jbc.M003929200","volume":"275","author":"JE Angell","year":"2000","unstructured":"Angell JE, et al. Identification of GRIM-19, a novel cell death-regulatory gene induced by the interferon-beta and retinoic acid combination, using a genetic approach. J Biol Chem. 2000;275(43):33416\u201326.","journal-title":"J Biol Chem"},{"issue":"19","key":"963_CR11","doi-asserted-by":"crossref","first-page":"19021","DOI":"10.1074\/jbc.M413776200","volume":"280","author":"N Barnich","year":"2005","unstructured":"Barnich N, et al. GRIM-19 interacts with nucleotide oligomerization domain 2 and serves as downstream effector of anti-bacterial function in intestinal epithelial cells. J Biol Chem. 2005;280(19):19021\u20136.","journal-title":"J Biol Chem"},{"issue":"16","key":"963_CR12","doi-asserted-by":"crossref","first-page":"9342","DOI":"10.1073\/pnas.1633516100","volume":"100","author":"J Zhang","year":"2003","unstructured":"Zhang J, et al. The cell death regulator GRIM-19 is an inhibitor of signal transducer and activator of transcription 3. Proc Natl Acad Sci U S A. 2003;100(16):9342\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"19","key":"963_CR13","doi-asserted-by":"crossref","first-page":"8447","DOI":"10.1128\/MCB.24.19.8447-8456.2004","volume":"24","author":"G Huang","year":"2004","unstructured":"Huang G, et al. GRIM-19, a cell death regulatory protein, is essential for assembly and function of mitochondrial complex I. Mol Cell Biol. 2004;24(19):8447\u201356.","journal-title":"Mol Cell Biol"},{"issue":"8","key":"963_CR14","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1158\/1535-7163.MCT-09-1147","volume":"9","author":"T Okamoto","year":"2010","unstructured":"Okamoto T, et al. Overexpression of GRIM-19 in cancer cells suppresses STAT3-mediated signal transduction and cancer growth. Mol Cancer Ther. 2010;9(8):2333\u201343.","journal-title":"Mol Cancer Ther"},{"issue":"45","key":"963_CR15","doi-asserted-by":"crossref","first-page":"E4213","DOI":"10.1073\/pnas.1303760110","volume":"110","author":"S Kalakonda","year":"2013","unstructured":"Kalakonda S, et al. Monoallelic loss of tumor suppressor GRIM-19 promotes tumorigenesis in mice. Proc Natl Acad Sci U S A. 2013;110(45):E4213\u201322.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"963_CR16","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/art.38267","volume":"66","author":"YM Moon","year":"2014","unstructured":"Moon YM, et al. Gene associated with retinoid-interferon-induced mortality 19 attenuates murine autoimmune arthritis by regulation of th17 and treg cells. Arthritis Rheumatol. 2014;66(3):569\u201378.","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"963_CR17","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1634\/stemcells.2006-0234","volume":"25","author":"J Fukui","year":"2007","unstructured":"Fukui J, et al. Prevention of graft-versus-host disease by intra-bone marrow injection of donor T cells. Stem Cells. 2007;25(6):1595\u2013601.","journal-title":"Stem Cells"},{"issue":"5","key":"963_CR18","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.4049\/jimmunol.174.5.3051","volume":"174","author":"Y Zhang","year":"2005","unstructured":"Zhang Y, et al. Alloreactive memory T cells are responsible for the persistence of graft-versus-host disease. J Immunol. 2005;174(5):3051\u20138.","journal-title":"J Immunol"},{"issue":"1","key":"963_CR19","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1053\/j.seminhematol.2005.09.003","volume":"43","author":"HJ Deeg","year":"2006","unstructured":"Deeg HJ, Antin JH. The clinical spectrum of acute graft-versus-host disease. Semin Hematol. 2006;43(1):24\u201331.","journal-title":"Semin Hematol"},{"issue":"2","key":"963_CR20","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/0016-5085(86)90949-2","volume":"90","author":"GB McDonald","year":"1986","unstructured":"McDonald GB, et al. Intestinal and hepatic complications of human bone marrow transplantation. Part I. Gastroenterology. 1986;90(2):460\u201377.","journal-title":"Part I. Gastroenterology"},{"issue":"3","key":"963_CR21","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/0016-5085(86)91137-6","volume":"90","author":"GB McDonald","year":"1986","unstructured":"McDonald GB, et al. Intestinal and hepatic complications of human bone marrow transplantation. Part II. Gastroenterology. 1986;90(3):770\u201384.","journal-title":"Part II. Gastroenterology"},{"issue":"4","key":"963_CR22","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1002\/hep.23533","volume":"51","author":"GB McDonald","year":"2010","unstructured":"McDonald GB. Hepatobiliary complications of hematopoietic cell transplantation, 40\u00a0years on. Hepatology. 2010;51(4):1450\u201360.","journal-title":"Hepatology"},{"issue":"4","key":"963_CR23","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/hon.716","volume":"21","author":"P Reddy","year":"2003","unstructured":"Reddy P. Pathophysiology of acute graft-versus-host disease. Hematol Oncol. 2003;21(4):149\u201361.","journal-title":"Hematol Oncol"},{"issue":"5969","key":"963_CR24","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.1178334","volume":"327","author":"JJ O\u2019Shea","year":"2010","unstructured":"O\u2019Shea JJ, Paul WE. Mechanisms underlying lineage commitment and plasticity of helper CD4\u00a0+\u00a0T cells. Science. 2010;327(5969):1098\u2013102.","journal-title":"Science"},{"issue":"9","key":"963_CR25","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1073\/pnas.0915174107","volume":"107","author":"MA Curran","year":"2010","unstructured":"Curran MA, et al. PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors. Proc Natl Acad Sci USA. 2010;107(9):4275\u201380.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"963_CR26","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1084\/jem.20112275","volume":"209","author":"D Pardoll","year":"2012","unstructured":"Pardoll D, Drake C. Immunotherapy earns its spot in the ranks of cancer therapy. J Exp Med. 2012;209(2):201\u20139.","journal-title":"J Exp Med"},{"key":"963_CR27","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3389\/fimmu.2013.00163","volume":"4","author":"AJ Beres","year":"2013","unstructured":"Beres AJ, Drobyski WR. The role of regulatory T cells in the biology of graft versus host disease. Front Immunol. 2013;4:163.","journal-title":"Front Immunol"},{"issue":"7","key":"963_CR28","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1182\/blood-2009-12-255810","volume":"116","author":"P Ratajczak","year":"2010","unstructured":"Ratajczak P, et al. Th17\/Treg ratio in human graft-versus-host disease. Blood. 2010;116(7):1165\u201371.","journal-title":"Blood"},{"issue":"6","key":"963_CR29","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1158\/2159-8290.CD-13-0593","volume":"4","author":"S Baumgart","year":"2014","unstructured":"Baumgart S, et al. Inflammation-induced NFATc1-STAT3 transcription complex promotes pancreatic cancer initiation by KrasG12D. Cancer Discov. 2014;4(6):688\u2013701.","journal-title":"Cancer Discov"},{"issue":"3","key":"963_CR30","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.bbamcr.2006.12.007","volume":"1773","author":"MC Mulero","year":"2007","unstructured":"Mulero MC, et al. RCAN3, a novel calcineurin inhibitor that down-regulates NFAT-dependent cytokine gene expression. Biochim Biophys Acta. 2007;1773(3):330\u201341.","journal-title":"Biochim Biophys Acta"},{"issue":"8","key":"963_CR31","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1182\/blood.V99.8.3041","volume":"99","author":"UF Hartwig","year":"2002","unstructured":"Hartwig UF, et al. Murine acute graft-versus-host disease can be prevented by depletion of alloreactive T lymphocytes using activation-induced cell death. Blood. 2002;99(8):3041\u20139.","journal-title":"Blood"},{"issue":"4","key":"963_CR32","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1182\/blood-2008-08-172155","volume":"113","author":"LW Kappel","year":"2009","unstructured":"Kappel LW, et al. IL-17 contributes to CD4-mediated graft-versus-host disease. Blood. 2009;113(4):945\u201352.","journal-title":"Blood"},{"issue":"1","key":"963_CR33","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00003226-198801000-00008","volume":"7","author":"KF Heitman","year":"1988","unstructured":"Heitman KF, et al. Elevated tear IgG and conjunctival plasma cell infiltrate in a graft versus host disease patient. Cornea. 1988;7(1):57\u201362.","journal-title":"Cornea"},{"issue":"2","key":"963_CR34","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1182\/blood.V55.2.179.179","volume":"55","author":"O Ringden","year":"1980","unstructured":"Ringden O, et al. Increased in vitro B-cell IgG secretion during acute graft-versus-host disease and infection. Observations in 50 human marrow transplant recipients. Blood. 1980;55(2):179\u201386.","journal-title":"Blood"},{"issue":"3","key":"963_CR35","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/00007890-199209000-00014","volume":"54","author":"FW Symington","year":"1992","unstructured":"Symington FW, et al. The relationship of serum IL-6 levels to acute graft-versus-host disease and hepatorenal disease after human bone marrow transplantation. Transplantation. 1992;54(3):457\u201362.","journal-title":"Transplantation"},{"issue":"1","key":"963_CR36","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1158\/1078-0432.CCR-10-1198","volume":"17","author":"I Tawara","year":"2011","unstructured":"Tawara I, et al. Interleukin-6 modulates graft-versus-host responses after experimental allogeneic bone marrow transplantation. Clin Cancer Res. 2011;17(1):77\u201388.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"963_CR37","first-page":"99","volume":"15","author":"M Remberger","year":"1995","unstructured":"Remberger M, Ringden O, Markling L. TNF alpha levels are increased during bone marrow transplantation conditioning in patients who develop acute GVHD. Bone Marrow Transplant. 1995;15(1):99\u2013104.","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"963_CR38","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.4049\/jimmunol.1203428","volume":"192","author":"Y Liang","year":"2014","unstructured":"Liang Y, et al. IL-1beta and TLR4 signaling are involved in the aggravated murine acute graft-versus-host disease caused by delayed bortezomib administration. J Immunol. 2014;192(3):1277\u201385.","journal-title":"J Immunol"},{"issue":"9","key":"963_CR39","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1172\/JCI3906","volume":"102","author":"WJ Murphy","year":"1998","unstructured":"Murphy WJ, et al. Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice. J Clin Invest. 1998;102(9):1742\u20138.","journal-title":"J Clin Invest"},{"issue":"5","key":"963_CR40","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/nm.2128","volume":"16","author":"GM Bendle","year":"2010","unstructured":"Bendle GM, et al. Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy. Nat Med. 2010;16(5):565\u201370.","journal-title":"Nat Med"},{"issue":"4","key":"963_CR41","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.4049\/jimmunol.1200858","volume":"189","author":"LM Fulton","year":"2012","unstructured":"Fulton LM, et al. Attenuation of acute graft-versus-host disease in the absence of the transcription factor RORgammat. J Immunol. 2012;189(4):1765\u201372.","journal-title":"J Immunol"},{"issue":"18","key":"963_CR42","doi-asserted-by":"crossref","first-page":"4765","DOI":"10.1182\/blood-2011-09-377325","volume":"118","author":"T Teshima","year":"2011","unstructured":"Teshima T. Th1 and Th17 join forces for acute GVHD. Blood. 2011;118(18):4765\u20137.","journal-title":"Blood"},{"issue":"9","key":"963_CR43","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.bbmt.2008.06.007","volume":"14","author":"JE Foley","year":"2008","unstructured":"Foley JE, et al. Th2 cell therapy of established acute graft-versus-host disease requires IL-4 and IL-10 and is abrogated by IL-2 or host-type antigen-presenting cells. Biol Blood Marrow Transplant. 2008;14(9):959\u201372.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"14","key":"963_CR44","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1182\/blood-2010-10-311894","volume":"117","author":"M Ianni Di","year":"2011","unstructured":"Di Ianni M, et al. Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. Blood. 2011;117(14):3921\u20138.","journal-title":"Blood"},{"issue":"4","key":"963_CR45","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1189\/jlb.5A1114-532RR","volume":"97","author":"BC Betts","year":"2015","unstructured":"Betts BC, et al. CD4\u00a0+\u00a0T cell STAT3 phosphorylation precedes acute GVHD, and subsequent Th17 tissue invasion correlates with GVHD severity and therapeutic response. J Leukoc Biol. 2015;97(4):807\u201319.","journal-title":"J Leukoc Biol"},{"issue":"2","key":"963_CR46","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1189\/jlb.0313154","volume":"95","author":"BC Betts","year":"2014","unstructured":"Betts BC, et al. STAT5 polarization promotes iTregs and suppresses human T-cell alloresponses while preserving CTL capacity. J Leukoc Biol. 2014;95(2):205\u201313.","journal-title":"J Leukoc Biol"},{"issue":"2","key":"963_CR47","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.immuni.2012.05.027","volume":"37","author":"A Laurence","year":"2012","unstructured":"Laurence A, et al. STAT3 transcription factor promotes instability of nTreg cells and limits generation of iTreg cells during acute murine graft-versus-host disease. Immunity. 2012;37(2):209\u201322.","journal-title":"Immunity"},{"issue":"9","key":"963_CR48","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1161\/ATVBAHA.111.230573","volume":"31","author":"J Meloche","year":"2011","unstructured":"Meloche J, et al. RAGE-dependent activation of the oncoprotein Pim1 plays a critical role in systemic vascular remodeling processes. Arterioscler Thromb Vasc Biol. 2011;31(9):2114\u201324.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"963_CR49","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.4049\/jimmunol.172.6.3597","volume":"172","author":"S Diehl","year":"2004","unstructured":"Diehl S, et al. Inhibition of NFAT specifically in T cells prevents allergic pulmonary inflammation. J Immunol. 2004;172(6):3597\u2013603.","journal-title":"J Immunol"},{"issue":"5","key":"963_CR50","doi-asserted-by":"crossref","first-page":"R97","DOI":"10.1186\/ar2298","volume":"9","author":"T Kubota","year":"2007","unstructured":"Kubota T, et al. NF-kappaB inhibitor dehydroxymethylepoxyquinomicin suppresses osteoclastogenesis and expression of NFATc1 in mouse arthritis without affecting expression of RANKL, osteoprotegerin or macrophage colony-stimulating factor. Arthritis Res Ther. 2007;9(5):R97.","journal-title":"Arthritis Res Ther"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-016-0963-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T04:54:57Z","timestamp":1692420897000},"score":1,"resource":{"primary":{"URL":"http:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-016-0963-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,8]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["963"],"URL":"https:\/\/doi.org\/10.1186\/s12967-016-0963-0","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,8]]},"article-number":"206"}}